Fan, Zhen
Dani, Melanie
Femminella, Grazia D.
Wood, Melanie
Calsolaro, Valeria
Veronese, Mattia
Turkheimer, Federico
Gentleman, Steve
Brooks, David J.
Hinz, Rainer
Edison, Paul http://orcid.org/0000-0002-6551-2002
Funding for this research was provided by:
Medical Research Council
National Institute for Health Research
Imperial College Healthcare NHS Trust
Alzheimer’s Research UK
Article History
Received: 12 October 2017
Accepted: 19 February 2018
First Online: 9 March 2018
Compliance with ethical standards
:
: Dr. Edison was funded by the Medical Research Council and now by Higher Education Funding Council for England (HEFCE). He has also received grants from Alzheimer’s Research UK, Alzheimer’s Drug Discovery Foundation, Alzheimer’s Society, UK, Novo Nordisk, and GE Healthcare. He is also a consultant to Pfizer. Prof. Brooks has received research grants and non-financial support from the Medical Research Council, grants from Alzheimer’s Research Trust, during the conduct of the study; other from GE Healthcare, personal fees from AstraZeneca, personal fees from Cytox, personal fees from Shire, personal fees from Novartis, personal fees from GSK, Holland, personal fees from Navidea, personal fees from UCB, personal fees from Acadia, grants from Michael J Fox Foundation, grants from European Commission, outside the submitted work. Mattia Veronese is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and by King’s College London.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.